Prestigious Awards, Stock Price Updates, Conference Schedules, and Earnings Releases - Analyst Notes on Dow Chemical, EQT, Marathon Oil, Atlas Resource and Canadian Natural

NEW YORK, May 14, 2014 /PRNewswire/ --

Today, Analysts Review released its analysts' notes regarding The Dow Chemical Company (NYSE: DOW), EQT Corporation (NYSE: EQT), Marathon Oil Corporation (NYSE: MRO), Atlas Resource Partners, L.P. (NYSE: ARP) and Canadian Natural Resources Limited (NYSE: CNQ). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/2435-100free.

--
The Dow Chemical Company Analyst Notes
On May 2, 2014, The Dow Chemical Company (Dow) announced that it has received the prestigious Bronze Edison Award for its FILMTEC™ ECO Reverse Osmosis (RO) Elements in the Energy/Sustainability and Commercial Resource Management category on April 30, 2014. According to the Company, the judging committee recognized FILMTEC ECO Technology for its ability to significantly reduce the energy required to remove impurities from water. Commenting on the achievement, Snehal Desai, Global Business Director for Dow Water & Process Solutions, said, "The Edison Award recognition is very important to us, as it shows our technologies and innovations, like FILMTEC ECO Reverse Osmosis Elements, are making impacts on real-world issues like water and energy scarcity." The full analyst notes on Dow Chemical are available to download free of charge at:

http://www.analystsreview.com/2435-DOW-14May2014.pdf

--
EQT Corporation Analyst Notes
On May 9, 2014, the stock of EQT Corporation (EQT) declined 1.17% to close at $105.04. After opening the day's session at $106.53, the stock traded in a range of $104.39 - $106.88. During the session, a total of 4.07 million shares were traded, which was higher than its 30-day average daily volume of 1.66 million. Over the last 12 months, EQT's stock has gained 39.81%, outperforming the S&P 500 index which gained 16.36% during the same period. The full analyst notes on EQT are available to download free of charge at:

http://www.analystsreview.com/2435-EQT-14May2014.pdf

--
Marathon Oil Corporation Analyst Notes
On May 8, 2014, Marathon Oil Corporation (Marathon Oil) announced that John R. (J.R.) Sult, the Executive Vice President and CFO of the Company, will make a presentation at the UBS Global Oil and Gas Conference in Austin on May 20, 2014 at 8:40 a.m. CDT. The Company informed that a live webcast of the presentation will be available via Marathon Oil's website. The full analyst notes on Marathon Oil are available to download free of charge at:

http://www.analystsreview.com/2435-MRO-14May2014.pdf

--
Atlas Resource Partners, L.P. Analyst Notes
On May 7, 2014, Atlas Resource Partners, L.P. (ARP) released its Q1 2014 financial results, which showed that its net loss attributable to common limited partners and the general partner has widened to $15.2 million, or $0.28 per diluted share, during the quarter, from $7.3 million, or $0.17 per diluted share, in Q1 2013. On average, analysts polled by Reuters expected the Company to report a loss per share of $0.12 (excluding special items). ARP's adjusted EBITDA was $64.5 million in Q1 2014, compared to $31.4 million in the year-ago period. ARP stated that results during the quarter were adversely impacted by c.$3.5 million due to constrained production volumes caused by severe winter weather conditions. Revenues increased 40.4% YoY to $157.3 million in Q1 2014. In a separate released issued the same day, ARP informed that it will acquire approximately 47 million barrels of oil equivalent (Mmboe) of oil and natural gas liquids in the Rangely field, northwest Colorado, for $420 million. The full analyst notes on Atlas Resource are available to download free of charge at:

http://www.analystsreview.com/2435-ARP-14May2014.pdf

--
Canadian Natural Resources Limited Analyst Notes
On May 8, 2014, Canadian Natural Resources Limited (Canadian Natural) released its Q1 2014 financial results. The Company's net income during the quarter came in at C$622 million, or C$0.57 per diluted share, representing a nearly three-fold jump from C$213 million, or C$0.19 per diluted share, in Q1 2013. Canadian Natural's adjusted net income increased to C$921 million, or C$0.85 per diluted share. The Company's revenue during Q1 2014 increased 17.1% YoY to C$4.4 billion. Production during the quarter increased 0.6% YoY to 684,647 barrels of oil equivalent per day (before royalties). Canadian Natural informed that its average realized price (excluding risk management) for Crude Oil and Natural Gas Liquids was C$79.68 per bbl, compared to C$60.87 per bbl in Q1 2013; and the average realized price (excluding risk management) for natural gas increased to C$5.69 per Mcf from C$3.51 per Mcf in the year-ago period. The full analyst notes on Canadian Natural are available to download free of charge at:

http://www.analystsreview.com/2435-CNQ-14May2014.pdf

--
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

AnalystsReview.com

SOURCE Analysts Review